174 related articles for article (PubMed ID: 33179348)
1. Anti-aminoacyl-tRNA synthetases antibody positive overlap syndrome of systemic sclerosis and dermatomyositis associated with rapidly progressive interstitial lung disease.
Nishio M; Endo Y; Kosaka K; Saito S; Uehara A; Yamazaki S; Sekiguchi A; Ishikawa O; Motegi SI
J Dermatol; 2021 Feb; 48(2):e110-e111. PubMed ID: 33179348
[No Abstract] [Full Text] [Related]
2. [Interstitial lung disease in patients with connective tissue diseases].
Hirakata M; Nakamura K; Kaburaki J; Suwa A; Mimori T; Kanazawa M; Akizuki M
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Dec; 33 Suppl():268-76. PubMed ID: 8752518
[TBL] [Abstract][Full Text] [Related]
3. [Reliability and clinical utility of Enzyme-linked immunosorbent assay for detection of anti-aminoacyl-tRNA synthetase antibody].
Abe T; Tsunoda S; Nishioka A; Azuma K; Tsuboi K; Ogita C; Yokoyama Y; Furukawa T; Maruoka M; Tamura M; Yoshikawa T; Saito A; Sekiguchi M; Azuma N; Kitano M; Matsui K; Hosono Y; Nakashima R; Ohmura K; Mimori T; Sano H
Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(2):140-4. PubMed ID: 27212600
[TBL] [Abstract][Full Text] [Related]
4. Distinct clinical and histological features in dermatomyositis with anti-aminoacyl-tRNA synthetase antibodies.
Ishibuchi H; Motegi S; Kishi C; Amano H; Ishikawa O
J Dermatol; 2016 Aug; 43(8):978-80. PubMed ID: 26919552
[No Abstract] [Full Text] [Related]
5. Association of anti-aminoacyl-transfer RNA synthetase antibody and anti-melanoma differentiation-associated gene 5 antibody with the therapeutic response of polymyositis/dermatomyositis-associated interstitial lung disease.
Yoshida N; Okamoto M; Kaieda S; Fujimoto K; Ebata T; Tajiri M; Nakamura M; Tominaga M; Wakasugi D; Kawayama T; Kuwana M; Mimori T; Ida H; Hoshino T
Respir Investig; 2017 Jan; 55(1):24-32. PubMed ID: 28012490
[TBL] [Abstract][Full Text] [Related]
6. Clinical manifestations of skin, lung and muscle diseases in dermatomyositis positive for anti-aminoacyl tRNA synthetase antibodies.
Fukamatsu H; Hirai Y; Miyake T; Kaji T; Morizane S; Yokoyama E; Hamada T; Oono T; Koyama Y; Norikane S; Iwatsuki K
J Dermatol; 2019 Oct; 46(10):886-897. PubMed ID: 31418479
[TBL] [Abstract][Full Text] [Related]
7. Association of distinct clinical subsets with myositis-specific autoantibodies towards anti-155/140-kDa polypeptides, anti-140-kDa polypeptides, and anti-aminoacyl tRNA synthetases in Japanese patients with dermatomyositis: a single-centre, cross-sectional study.
Fujikawa K; Kawakami A; Kaji K; Fujimoto M; Kawashiri S; Iwamoto N; Aramaki T; Ichinose K; Tamai M; Kamachi M; Nakamura H; Ida H; Origuchi T; Ishimoto H; Mukae H; Kuwana M; Kohno S; Takehara K; Sato S; Eguchi K
Scand J Rheumatol; 2009; 38(4):263-7. PubMed ID: 19444719
[TBL] [Abstract][Full Text] [Related]
8. [Anti-PL-7, anti-PL-12, and other anti-aminoacyl tRNA synthetase antibodies].
Hirakata M
Nihon Rinsho; 2010 Jun; 68 Suppl 6():555-9. PubMed ID: 20942128
[No Abstract] [Full Text] [Related]
9. The comparison of nailfold videocapillaroscopy findings between anti-melanoma differentiation-associated gene 5 antibody and anti-aminoacyl tRNA synthetase antibody in patients with dermatomyositis complicated by interstitial lung disease.
Wakura R; Matsuda S; Kotani T; Shoda T; Takeuchi T
Sci Rep; 2020 Sep; 10(1):15692. PubMed ID: 32973255
[TBL] [Abstract][Full Text] [Related]
10. Dermatomyositis with Rapidly Progressive Interstitial Lung Disease Treated with Rituximab: A Report of 3 Cases in Japan.
Tokunaga K; Hagino N
Intern Med; 2017; 56(11):1399-1403. PubMed ID: 28566605
[TBL] [Abstract][Full Text] [Related]
11. Plasma homocysteine levels are positively associated with interstitial lung disease in dermatomyositis patients with anti-aminoacyl-tRNA synthetase antibody.
Sekiguchi A; Endo Y; Yamazaki S; Uchiyama A; Shimizu A; Motegi SI
J Dermatol; 2021 Jan; 48(1):34-41. PubMed ID: 32892413
[TBL] [Abstract][Full Text] [Related]
12. [Immunologic tests: Anti-PL 7 antibodies, anti-PL-12 antibodies, and other anti-aminoacyl tRNA synthetase antibodies].
Hirakata M; Katsuki Y; Sato S
Nihon Rinsho; 2005 Jul; 63 Suppl 7():508-11. PubMed ID: 16111316
[No Abstract] [Full Text] [Related]
13. Comparison of long-term prognosis and relapse of dermatomyositis complicated with interstitial pneumonia according to autoantibodies: anti-aminoacyl tRNA synthetase antibodies versus anti-melanoma differentiation-associated gene 5 antibody.
Isoda K; Kotani T; Takeuchi T; Kiboshi T; Hata K; Ishida T; Otani K; Kamimori T; Fujiwara H; Shoda T; Makino S
Rheumatol Int; 2017 Aug; 37(8):1335-1340. PubMed ID: 28451794
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.
Hozumi H; Fujisawa T; Nakashima R; Johkoh T; Sumikawa H; Murakami A; Enomoto N; Inui N; Nakamura Y; Hosono Y; Imura Y; Mimori T; Suda T
Respir Med; 2016 Dec; 121():91-99. PubMed ID: 27888997
[TBL] [Abstract][Full Text] [Related]
15. Reaction of anti-OJ autoantibodies with components of the multi-enzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tRNA synthetase.
Targoff IN; Trieu EP; Miller FW
J Clin Invest; 1993 Jun; 91(6):2556-64. PubMed ID: 8514867
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of anti-aminoacyl-tRNA synthetase antibodies in polymyositis/dermatomyositis-associated interstitial lung disease: a retrospective case control study.
Hozumi H; Enomoto N; Kono M; Fujisawa T; Inui N; Nakamura Y; Sumikawa H; Johkoh T; Nakashima R; Imura Y; Mimori T; Suda T
PLoS One; 2015; 10(3):e0120313. PubMed ID: 25789468
[TBL] [Abstract][Full Text] [Related]
17. Seasonal and residential clustering at disease onset of anti-MDA5-associated interstitial lung disease.
Nishina N; Sato S; Masui K; Gono T; Kuwana M
RMD Open; 2020 Jun; 6(2):. PubMed ID: 32506053
[TBL] [Abstract][Full Text] [Related]
18. Establishment of an ELISA to detect anti-glycyl-tRNA synthetase antibody (anti-EJ), a serological marker of dermatomyositis/polymyositis and interstitial lung disease.
Hane H; Muro Y; Watanabe K; Ogawa Y; Sugiura K; Akiyama M
Clin Chim Acta; 2014 Apr; 431():9-14. PubMed ID: 24508626
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance and new detection system of autoantibodies in myositis with interstitial lung disease.
Nakashima R; Hosono Y; Mimori T
Lupus; 2016 Jul; 25(8):925-33. PubMed ID: 27252271
[TBL] [Abstract][Full Text] [Related]
20. Two cases with autoantibodies to small ubiquitin-like modifier activating enzyme: A potential unique subset of dermatomyositis-associated interstitial lung disease.
Gono T; Tanino Y; Nishikawa A; Kawamata T; Hirai K; Okazaki Y; Shibata Y; Kuwana M
Int J Rheum Dis; 2019 Aug; 22(8):1582-1586. PubMed ID: 31050194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
